Publication date: Jun 19, 2024
Our study aims to delineate the phenotypes of chronic neuropsychiatric symptoms among adult subjects recovering from their first COVID that occurred more than one year ago. We also aim to explore the clinical and socioeconomic risk factors of having a high loading of chronic neuropsychiatric symptoms. We recruited a post-COVID group who suffered from their first pre-Omicron COVID more than a year ago, and a control group who had never had COVID. The subjects completed app-based questionnaires on demographic, socioeconomic and health status, a COVID symptoms checklist, mental and sleep health measures, and neurocognitive tests. The post-COVID group has a statistically significantly higher level of fatigue compared to the control group (p
Open Access PDF
Semantics
| Type | Source | Name |
|---|---|---|
| disease | MESH | infection |
| disease | MESH | Long Covid |
| disease | VO | vaccination |
| disease | MESH | syndrome |
| disease | MESH | SARS CoV 2 infection |
| disease | MESH | neuroinflammation |
| disease | MESH | sequelae |
| disease | IDO | symptom |
| drug | DRUGBANK | Coenzyme M |
| disease | MESH | mental illness |
| disease | IDO | history |
| disease | MESH | pneumonia |
| drug | DRUGBANK | Oxygen |
| disease | MESH | Anxiety Disorder |
| drug | DRUGBANK | Indoleacetic acid |
| disease | MESH | Insomnia |
| disease | MESH | alcoholism |
| pathway | KEGG | Alcoholism |
| disease | VO | protocol |
| drug | DRUGBANK | Aspartame |
| disease | IDO | algorithm |
| disease | IDO | process |
| disease | VO | frequency |
| disease | MESH | re infection |
| disease | MESH | daytime sleepiness |
| disease | VO | age |
| disease | MESH | education level |
| disease | MESH | suicidal ideation |
| disease | MESH | chronic pain |
| disease | MESH | hypertension |
| disease | VO | vaccine |
| disease | MESH | Chronic Disease |